22 reports

  • Target
  • 5. All the trials included are unique trials.

Nephropathy Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Nephropathy Global Clinical Trials Review, H1, 2018" provides an overview of Nephropathy clinical trials scenario.This report provides top line data relating to the clinical trials on Nephropathy. Report...

  • Clinical Trial
  • Hormone
  • Hormones
  • Therapy
  • Type 2 Diabetes
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Anti Rheumatic
  • Clinical Trial
  • Hormone
  • Pain Relief
  • Therapy
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Anti Rheumatic
  • Clinical Trial
  • Hormone
  • Pain Relief
  • Therapy
  • Clinical Trial profile. 733 Trial Title
  • 5. All the trials included are unique trials.

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario....

  • Clinical Trial
  • Genitourinary System Disease
  • Hormone
  • Hormones
  • Pharmaceutical
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Hormone
  • Therapy
  • World
  • Bayer AG

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Hormone
  • Pharmaceutical

The prominent features of this report are - ##.

  • Clinical Trial
  • Dementia
  • Hormone
  • Neurology
  • Pharmaceutical

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Antipsychotic
  • Bipolar Disorder
  • Clinical Trial
  • Depression
  • Hormone
  • Clinical Trial profile. 1618 Trial Title

Patients with HER##-high breast cancer (HER## IHC ##+ or IHC##+ and FISH-positive) had to have received previous treatment with trastuzumab, pertuzumab, and T-DM##.

  • Breast Cancer
  • Chemotherapy
  • Clinical Trial
  • Hormone
  • Monoclonal Antibody
  • Clinical Trial profile. 476 Trial Title
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database

Merck KG ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## Ferring Holding SA ## ## ## ## ## ## Eugonia IBSA Institut Biochimique SA ## ## ## ## ## ## ## ## ## ## ## ## LO. LI.

  • Clinical Trial
  • Endocrine Disease
  • Hormone
  • Pharmaceutical
  • World
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Hormone
  • Hospital
  • Renal Disease
  • Therapy
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database

The prominent features of this report are - ##.

  • Clinical Trial
  • Genitourinary System Disease
  • Hormone
  • World
  • Pfizer Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Seed Oil on the Serum Concentration of Interleukin ## and Interleukin ## in Hemodialysis Patients Anti Inflammatory Effects of Cannabis Sativa L.

  • Clinical Trial
  • Drug Discovery And Development
  • Hormone
  • Therapy
  • World
  • Clinical Trial profile. 863 Trial Title
  • Clinical Trial profile. 2327 Trial Title

Renal Failure Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Renal Failure Global Clinical Trials Review, H2, 2016" provides an overview of Renal Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Failure. Report includes an...

  • Clinical Trial
  • Drug Discovery And Development
  • Hormone
  • Pharmaceutical
  • World
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Hormone
  • Hospital
  • Neurological Disorder
  • Neurology
  • 5. All the trials included are unique trials.

Patients were randomized ##:## to receive either a six-week course of AEVI-## or placebo, with a one-week follow-up.

  • Clinical Trial
  • Hormone
  • Neurological Disorder
  • Neurology
  • Therapy

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Chronic Pain
  • Clinical Trial
  • Hormone
  • Hospital
  • Neurology
  • Clinical Trial Profile Snapshots

## ## ## ## ## Novartis AG ## ## ## ## ## ## Merck & Co., Inc. ## ## ## ## ## ## Pfizer Inc. ## ## ## ## ## ## Abbott Laboratories ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ## Allergan

  • Clinical Trial
  • Hormone
  • Pharmaceutical
  • World
  • Product Initiative
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Hormone
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Antipsychotic
  • Clinical Trial
  • Hormone
  • Pharmaceutical
  • Psychotic Disorder
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Hormone
  • Neurological Disorder
  • Therapy
  • Official Title
  • 1 1 ESTROGEN RECEPTOR ANTAGONIST ESTROGEN RECEPTOR (ER)

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Endocrine Disease
  • Hormone
  • Pharmaceutical
  • World